CAM
GMED icon

Chesapeake Asset Management’s Globus Medical GMED Stock Holding History

Chesapeake Asset Management’s Portfolio GMED Stock Details GMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-109
Closed -$9.52K – 353
2025
Q4 		$9.52K Buy
+109
New +$8.27K 0.01% 257

Other funds holding GMED

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
SC
Sculptor Capital New York $9.61B AUM 27.49% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Bank of Montreal
Bank of Montreal Toronto, Ontario, Canada $269B AUM 31.4% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Chesapeake Asset Management's GMED Position: Q1 2026 in Review

Chesapeake Asset Management sold out of Globus Medical (GMED) in Q1 2026, closing a stake of 109 shares — an estimated $9.52K sold.

Chesapeake Asset Management first reported a position in GMED in Q4 2025 and held it in 1 quarter. The position peaked at $9.52K in Q4 2025. 602 funds tracked by Wall St. Rank hold GMED as of Q1 2026.

  • Chesapeake Asset Management reported no remaining Globus Medical position as of Q1 2026 after selling out during the quarter.
  • Chesapeake Asset Management sold 109 Globus Medical shares in Q1 2026, an estimated $9.52K.
  • Chesapeake Asset Management first reported a position in Globus Medical in Q4 2025 and held it in 1 quarter.
  • Chesapeake Asset Management's Globus Medical position peaked at $9.52K in Q4 2025.
  • 602 funds tracked by Wall St. Rank held Globus Medical as of Q1 2026.

Based on Chesapeake Asset Management's 13F filing for Q1 2026, filed 12 May 2026.